Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies
Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1903-1917
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies
Tarfah Al‐Warhi, Al-Aliaa M. Sallam, Loah R. Hemeda, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1262-1262
Open Access | Times Cited: 63
The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1H-Indole Derivative: In Silico and In Vitro Approaches
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Processes (2022) Vol. 10, Iss. 7, pp. 1391-1391
Open Access | Times Cited: 43
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation
Alaa Elwan, Abdallah E. Abdallah, Hazem A. Mahdy, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 5047-5047
Open Access | Times Cited: 43
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 777-792
Closed Access | Times Cited: 41
(E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies
Reda G. Yousef, Hazem Elkady, Eslam B. Elkaeed, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7719-7719
Open Access | Times Cited: 37
New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136336-136336
Closed Access | Times Cited: 30
Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?
Opeyemi Iwaloye, Paul Olamide Ottu, Femi Olawale, et al.
Informatics in Medicine Unlocked (2023) Vol. 41, pp. 101332-101332
Open Access | Times Cited: 28
Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies
Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11535-11550
Open Access | Times Cited: 27
Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 26
Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Computational Biology and Chemistry (2023) Vol. 107, pp. 107953-107953
Closed Access | Times Cited: 20
New 2-Indolinone-Indole Hybrid Compounds Carrying a Benzoyl Moiety as Tyrosine Kinase Inhibitors
Merve Camci, Tuğçe Cinek, Gökçe Cihan‐Üstündağ, et al.
(2025)
Closed Access
New 2-indolinone-indole hybrid compounds carrying a benzoyl moiety as tyrosine kinase inhibitors
Merve Camcı-Eren, Tuğçe Cinek, Gökçe Cihan‐Üstündağ, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108203-108203
Closed Access
2‐Indolinone: An Anticancer Scaffold, Overview of the Studies and Approaches (2017–2024)
Taha Koulani, Asu Büşra Temizer, Nilgün Karalı
ChemistrySelect (2025) Vol. 10, Iss. 5
Closed Access
Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII
Tarfah Al‐Warhi, Mostafa M. Elbadawi, Alessandro Bonardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2635-2643
Open Access | Times Cited: 32
New Anticancer Theobromine Derivative Targeting EGFRWT and EGFRT790M: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5859-5859
Open Access | Times Cited: 31
Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer
Esraa A. Abdelsalam, Amer Ali Abd El‐Hafeez, Wagdy M. Eldehna, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2265-2282
Open Access | Times Cited: 30
Thiazolidin-2,4-Dione Scaffold: An Insight into Recent Advances as Antimicrobial, Antioxidant, and Hypoglycemic Agents
Harsh Kumar, Navidha Aggarwal, Minakshi Gupta Marwaha, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6763-6763
Open Access | Times Cited: 27
Synthesis and Anticancer Evaluation of Novel Indole Based Arylsulfonylhydrazides against Human Breast Cancer Cells
Aysha Gaur, Mudasir Nabi Peerzada, Nashrah Sharif Khan, et al.
ACS Omega (2022) Vol. 7, Iss. 46, pp. 42036-42043
Open Access | Times Cited: 26
Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties
Samaa Saied, Moataz A. Shaldam, Mostafa M. Elbadawi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115707-115707
Closed Access | Times Cited: 19
Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression
Aml Ghanem, Mohamed A. Ali, Mohamed A. Elkady, et al.
Pathology - Research and Practice (2023) Vol. 250, pp. 154807-154807
Closed Access | Times Cited: 18
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Life (2023) Vol. 13, Iss. 1, pp. 191-191
Open Access | Times Cited: 15
Design, synthesis, in silico studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers
Abdulrahman M. Saleh, Hazem A. Mahdy, Mohamed Ayman El‐Zahabi, et al.
RSC Advances (2023) Vol. 13, Iss. 32, pp. 22122-22147
Open Access | Times Cited: 15
Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment
Noura S. Hanafy, Nada A. A. M. Aziz, Sanadelaslam S. A. El‐Hddad, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 7
Closed Access | Times Cited: 14
New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations
Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 14, pp. 1233-1250
Closed Access | Times Cited: 14
Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors: In vitro and in silico studies
Ibrahim H. Eissa, Hazem Elkady, Mahmoud Rashed, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24005-e24005
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top